Avita Medical | 1811094D - Current Liabilities


Avita Medical reported AUD68.71M in Current Liabilities for its fiscal semester ending in June of 2026.





Current Liabilities Change Date
Accuray USD 199.44M 4.83M Dec/2025
Celltrion KRW 288.01B 4.7B Jun/2026
Clinuvel Pharmaceuticals AUD 17.85M 9.36M Dec/2025
Cochlear AUD 558.9M 43.4M Dec/2025
CSL USD 4.61B 207M Dec/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 28.51M 5.87M Sep/2026
Divis Laboratories Ltd INR 27.07B 6.64B Sep/2026
Kangmei Pharma CNY 5.1B 280.48M Jun/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Malin Corporation EUR 1000K 500K Dec/2024
Mayne Pharma AUD 313.94M 18.28M Jun/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Nanosonics AUD 36.59M 3.2M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organigram Holdings CAD 107.28M 18.54M Jun/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pacific Edge NZD 6.82M 400K Jun/2026
Pharma Mar EUR 125.39M 26.97M Sep/2026
Polynovo AUD 22.81M 5.07M Dec/2025
PYC Therapeutics AUD 11.01M 1.31M Dec/2025
Qiagen NV USD 581.45M 102.34M Jun/2026
Ramsay Health Care AUD 3.95B 514.2M Dec/2025
ResMed USD 1.4B 43.9M Jun/2026
Sartorius EUR 1.55B 102.8M Sep/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Telix Pharmaceuticals AUD 242.34M 10.72M Jun/2026
Tilray USD 259.32M 8.32M Sep/2025
Zealand Pharma A/S 404M 260.96M Mar/2026
Zz Pientze Pharmaceu CNY 2.74B 277.02M Sep/2026